Incyte Corporation logo
Incyte Corporation INCY
€ 104.23 -1.14%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 29.10.2026

Incyte Corporation DSO | INCY

DSO Jährlich Incyte Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
66.6 68.7 68.6 67.8 67.1 54.1 52.2 59.7 63.3 49.1 55.4 41.3 36.4 87.2 24.8 6.12 - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
87.2 6.12 54.3

DSO Vierteljährlich Incyte Corporation

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
69.2 59.3 74.4 58.1 58.1 62.5 72.6 62.4 60 64.9 77.1 63.1 64.3 60.3 71.6 62.2 72.1 62.3 73.3 59.9 53.6 54 66.3 55.7 67.6 51 53 46.1 47.9 47.1 50.6 48 57.2 46.9 58.1 47.7 44 57.9 46.8 39.2 44.2 42.8 37.4 37.7 39.4 40.5 36.5 61.7 36.1 42.9 41.5 32.2 32.5 24.9 63.5 35.1 22.9 14.2 24.5 14 13.2 51.4 -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
77.1 13.2 50.6

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Galapagos NV Galapagos NV
GLPG
56.5 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
178 - -4.36 % $ 27 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
33.4 $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
36.8 $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
17.8 - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
13.6 - - $ 35.3 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
75.3 - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
21.2 - -0.04 % $ 2.62 B usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
158 - -23.04 % $ 26.6 M usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
136 - - $ 69.7 B britainBritain
Guardion Health Sciences Guardion Health Sciences
GHSI
62.6 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
84.9 - - $ 109 M usaUSA
ImmunoGen ImmunoGen
IMGN
121 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
114 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
740 - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
260 - -2.99 % $ 2.47 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
0.653 - - $ 546 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
96.4 - - $ 35.4 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31.4 - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
18.3 - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
18.4 - - $ 127 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
211 $ 84.95 0.13 % $ 7.99 B usaUSA
Gilead Sciences Gilead Sciences
GILD
57.8 $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
2.46 $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
56.5 - - $ 2.02 B usaUSA
Orgenesis Orgenesis
ORGS
22.6 - -33.86 % $ 61.2 M usaUSA